Edison Investment Research is terminating coverage on FinLab (A7A), The Scottish Investment Trust (SCIN), and Telix Pharmaceuticals (TLX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
The Scottish Investment Trust - Termination of coverage
- Published:
30 Nov 2021 -
Author:
Neil Shah -
Pages:
3
Edison Investment Research is terminating coverage on FinLab (A7A), The Scottish Investment Trust (SCIN), and Telix Pharmaceuticals (TLX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.